Genomic differences linked to immune system were found to play an important role in lung cancer development. That finding, published April in Nature Communications, reveals potential for developing new therapeutics that could boost immune activity to prevent or halt progression of the disease, says Avrum Spira, the study's senior author.
He says that the newly identified genomic differences can be detected in normal airway tissue before any precancerous activity begins, which could potentially ...
↧